Neisseria meningitidis is second only to Haemophilus influenzae as a cause of bacterial meningitis in the United States and is a major human pathogen worldwide (6) . Polysaccharide vaccines offer protection against infection by organisms from the A, C, Y, and W-135 capsular serogroups, but no effective vaccine yet exists for serogroup B meningococci. Serogroup B organisms are currently responsible for the majority of meningococcal diseases in the United States and Western Europe (6) . Moreover, in the age group (under 2 years) most susceptible to disease, the immune response to serogroup A and C polysaccharides is poor (9) .
Consequently, in addition to group-specific polysaccharides, other antigens must be identified to achieve broadly effective immunoprophylaxis against meningococcal disease. Several recent observations suggest that iron acquisition mechanisms of meningococci might provide such targets. Many studies suggest that iron acquisition is important for bacterial pathogens, including N. meningitidis (5, 27, 28) . Holbein (13) showed that the use of transferrin (TF) iron is a critical factor in maintaining meningococcemia in experimentally infected mice. Most bacteria manufacture ironchelating compounds (siderophores) to acquire essential iron from their environment (22) . Siderophore production enhances the virulence of many bacteria, probably by increasing the availability of iron bound to host proteins such as TF and lactofemn (LF). These two iron-binding proteins are thought to be the primary iron sources available to bacterial pathogens in plasma and on mucosal surfaces, respectively (27) . Although Yancey and Finkelstein (32) reported that meningococci produce minute quantities of a hydroxamate siderophore, other studies have failed to detect meningococcal siderophores (1, 26, 29) . Nevertheless, all meningococci can utilize partially saturated TF and LF as sole sources of iron for growth (19, 20, 26 20) . The mechanism by which meningococci acquire iron from TF is unclear, but it is known that TF is not internalized as iron is removed and that digestion of the meningococcal cell surface with trypsin inhibits iron uptake from TF (26) . These observations imply that the meningococcus may possess cell surface receptors involved in acquisition of iron from TF and perhaps from other iron-binding proteins.
Iron-limited growth of many bacteria derepresses the synthesis of a variety of outer membrane proteins, many of which are critically involved in iron uptake (23) . For example, in Escherichia coli iron-repressible proteins (FeRPs) varying in molecular mass from 74 to 81 kilodaltons (kDa) are outer membrane receptors for various ferri-siderophore complexes (11, 12, 18, 30) . These FeRPs are expressed in the membranes of E. coli isolated from experimentally infected guinea pigs (10) , suggesting their importance during infection. Meningococci also possess outer membrane FeRPs (Fig. 1 (Fig. 1) . SDS gels stained with Coomassie blue showed FeRPs of about 70 and 105 kDa in all strains (Fig. 1) . SDS gels stained with silver showed an FeRP of about 94 kDa in all strains and an FeRP of about 88 kDa in all strains except JB503. Other FeRPs in the size range of 84 to 110 kDa were seen in strains JB501, JB502, and JB503. Mietzner et al. (21) recently described a 37-kDa FeRP in N. meningitidis, using 9.5 to 12.5% SDS-PAGE gradient gels containing 70 mM NaCl. However, this protein does not appear to be expressed in all strains of meningococci grown in our defined, iron-limited medium ( Fig. 1 (1) and convalescent (2) sera from the patient with strain JB502 to proteins from the homologous infecting strain JB502. Immunoreactive FeRPs are marked with arrows. Sera were diluted 1:200 (A) or 1:50 (B). Molecular weights are indicated in thousands (K).
for convalescent serum (1:200 for IgG antibody experiments and 1:50 for IgM antibody experiments); similar dilutions of pooled normal human serum also lacked reactivity. Convalescent serum from each patient contained IgG and IgM antibodies that bound to the 70-kDa FeRP and IgG antibody that bound to the 94-kDa FeRP from the homologous isolate ( Fig. 2 ; other data not shown). Convalescent sera from all patients except the patient whose culture yielded strain JB503 contained IgG antibody that bound to the 88-kDa FeRP from the homologous isolate; strain JB503 did not make a significant amount of an FeRP of this molecular weight (Fig. 1) . Although IgG or IgM antibodies against other FeRPs were seen in individual homologous sera, as for instance the 37-kDa FeRP in JB502 (Fig. 2A, lane 2b) , the only consistent immunoreactivity was directed against the 70-, 88-, and 94-kDa FeRPs. Very high-molecular-weight FeRPs bound antibody in some experiments (Fig. 3, lanes (25) .
Antigenic cross-reactivity of meningococcal FeRPs was investigated by probing membranes from all four strains with convalescent sera from the two patients whose cultures yielded JB501 and JB502 ( Fig. 3 ; other data not shown). These two patients produced IgG antibodies that bound to the 70-and 94-kDa FeRPs in all strains and IgM antibodies that bound to all 70-kDa FeRPs, suggesting that these proteins share common immunoreactivity. Antibody from each patient also bound to certain other heterologous FeRPs (Fig. 3) .
We were particularly interested in the observation that the 70-kDa FeRP in these strains might be cross-reactive, since a meningococcal mutant lacking the 70-kDa FeRP has been isolated. This mutant is unable to internalize appreciable amounts of 55Fe bound to TF or LF (7) . Therefore, we raised monospecific rabbit antiserum against purified 70-kDa FeRP isolated from strain FAM20 and used this to probe membranes of all four strains (Fig. 4) 
